Cite
MLA Citation
Colin Weekes et al.. “A Phase Ib Study to Evaluate the MEK Inhibitor Cobimetinib in Combination with the ERK1/2 Inhibitor GDC‐0994 in Patients with Advanced Solid Tumors.” Oncologist, vol. 25, 2020, pp. 833–e1438. http://access.bl.uk/ark:/81055/vdc_100112032936.0x000038